← FDA Medical Device Classifications

Prostrate Cancer Genes Nucleic Acid Amplification Test System

OYM · Class III — High Risk (PMA approval required, life-sustaining) · Unknown

Classification

FDA Product Code
OYM
Device class
Class III — High Risk (PMA approval required, life-sustaining)
Regulation
Review panel
IM
Medical specialty
Unknown
Submission type
2
GMP exempt
N
Life sustaining
N
Implant
N
Third-party review
N

Definition

An in vitro nucleic acid amplification test that measures the concentration of prostate cancer genes.

Market data

Cleared 510(k) submissions
0
Registered establishments
0

Source

Authoritative
FDA Device Classification database
Machine
JSON-LD · Markdown